Dow Looks to Reclaim Friday Losses as Stocks Rise

The blue-chip index is back above the 30,000 level

Deputy Editor
Oct 17, 2022 at 12:06 PM
facebook twitter linkedin

Stocks are starting the week off strong, extending this morning's gains at midday. The Dow Jones Industrial Average (DJI) is up 504 points at last glance, with help from surging Microsoft (MSFT) stock, and looking to recover from Friday's selloff that sent it below the psychologically significant 30,000 level. Earnings season is rolling in, with reports from several bank names for investors to unpack. Meanwhile, the Empire State manufacturing index fell for the third-straight month, dropping to -9.1, compared to expectations of -5. 

Continue reading for more on today's market, including:

  • Biotech stock hit with yet another bear note
  • Bank of America posts upbeat quarterly results. 
  • Plus, NOK puts pop; LFG soars on buyout; and NGM plummets into penny stock territory. 

mmc Oct17

Nokia Oyj (NYSE:NOK) put options are flying off the shelves today. So far, 17,000 puts have been exchanged -- 21 times the intraday average -- in comparison to 8,054 calls. The most popular contract is the October 4.50 put, expiring at the end of this week. The stock is receiving attention today, after news that it will build a new research and development (R&D) hub in Ottawa, ON. At last glance, NOK was up 3.4% to trade at $4.60, climbing further from its Sep. 27, 18-month low of $4.19, with long-term pressure looming above at the 180-day moving average. 

NOK Oct17

Near the top of the New York Stock Exchange (NYSE) this afternoon Archaea Energy Inc (NYSE:LFG), last seen up 52.4% to trade at $25.73, and earlier hit a record high of $25.96. Today's pop comes after news that BP (BP) is buying the renewable energy company for $26 per share in cash -- a value of $4.1 billion. 

Meanwhile, NGM Biopharmaceuticals Inc (NASDAQ:NGM) is at the bottom of the Nasdaq, down 72.9% at $3.13 and plummeting into penny stock territory from last session's close at $11.55. Weighing on the shares today is news that the company's eye disease drug, NGM621, failed in a mid-stage trial. Now trading at record lows, NGM is down 82.3%. 


Minimize Risk While Maximizing Profits

There is no options strategy like this one, which consistently minimizes risk while maintaining maximum profits. Perfect for traders looking for ways to control risk, reduce losses, and increase the likelihood of success when trading calls and puts. The Schaeffer’s team has over 41 years of options trading success targeting +100% gains on every trade. Rest assured your losses are effectively limited to your initial cost at the time of making your move! Don't waste another second... join us right now before the next trade is released! 



Special Offers from Schaeffer's Trading Partners